Globally accessible therapy is found to protect against lethal inflammation from COVID-19 in animal models

Researchers have found that a widely available and inexpensive drug targeting inflammatory genes has reduced morbidity and mortality in mice infected with SARS-CoV-2, the virus that causes COVID-19.